Back

Efficacy and safety of vernakalant for cardioversion of recent-onset atrial fibrillation in real-world clinical practice: the SPECTRUM post-approval safety study

2 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Atrial fibrillation and oral anticoagulation 4 Acute Management ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Juha Hartikainen

Kuopio University Hospital, Kuopio (Finland)

8 More presentations in this session

Presentation thumbnail
Doctor T. Chao (Taipei, TW)
Abstract
Presentation thumbnail
Doctor P. Rasmussen (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Associate Professor S. Choi (Daegu, KR)
Abstract Slides
Presentation thumbnail
Doctor G. Vanerio (Montevideo, UY)
Abstract
Presentation thumbnail
Professor C. Coleman (Storrs, US)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Atrial fibrillation and oral anticoagulation 4

The Event

Event poster

ESC Congress 2019

2 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
AF-CARE: “R” Rate and rhythm control
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources